{Reference Type}: Case Reports
{Title}: A Case of Recurrent Malignant Melanoma of the Left Foot with In-Transit Metastases.
{Author}: Olivieri DJ;Heffernan DS;Koness RJ;
{Journal}: R I Med J (2013)
{Volume}: 104
{Issue}: 7
{Year}: Sep 2021 1
暂无{Abstract}: We report a 73-year-old male with recurrent amelanotic malignant melanoma of the left foot with in-transit metastases to the left thigh. In-transit metastatic melanoma can often represent a diagnostic and therapeutic challenge for physicians. This patient was treated with talimogene laherparepvec injections (T-VEC; Imlygic) in the left inguinal and the left plantar region every two weeks for one year as oncolytic viral therapy for advanced non- operable malignant melanoma. He then received consistent follow-up including blood work and PET scans every four months, and he also required further lymph node surgical dissection. To date, our patient has survived 3 years and 11 months, which is 27 months longer than the esti- mated median survival of 1 year 8 months for patients diagnosed with in-transit metastatic melanoma.